What provided guidance for industry on possible process for evaluating the potential effects of antimicrobial new animal drugs on non-target bacteria, and risk assessment for microbial food safety?

• A. Guidance 152
• B. Guidance 149
• C. Guidance 140
• D. Guidance 160

Answer: (A)

The question is testing knowledge of which Guidance for Industry document specifically tells industry how to evaluate the effects of antimicrobial new animal drugs on non-target microorganisms and how to conduct a microbial food safety risk assessment. Guidance for Industry 152 is the document that provides that framework, outlining the process and considerations for assessing potential impacts on non-target bacteria and the associated risk to human food safety. It covers what kinds of studies and data are needed, how to think about ecological effects and resistance, and how to frame a risk assessment related to the food supply.

The other guidance documents address different regulatory topics or aspects of antimicrobial drug development and approval, rather than this particular focus on non-target microbial effects and microbial food safety risk assessment.